Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Zürn A[au]:

Sensing G protein-coupled receptor activation. Ambrosio M et al. Neuropharmacology. (2011)

Acetylcholine receptor and myasthenia gravis. Fulpius BW et al. Ann N Y Acad Sci. (1976)

Sustained delivery of GDNF: towards a treatment for Parkinson's disease. Zurn AD et al. Brain Res Brain Res Rev. (2001)

Search results

Items: 1 to 50 of 74

1.

Single-molecule analysis of fluorescently labeled G-protein-coupled receptors reveals complexes with distinct dynamics and organization.

Calebiro D, Rieken F, Wagner J, Sungkaworn T, Zabel U, Borzi A, Cocucci E, Zürn A, Lohse MJ.

Proc Natl Acad Sci U S A. 2013 Jan 8;110(2):743-8. doi: 10.1073/pnas.1205798110. Epub 2012 Dec 24.

2.

Rotational diffusion of the α(2a) adrenergic receptor revealed by FlAsH labeling in living cells.

Spille JH, Zürn A, Hoffmann C, Lohse MJ, Harms GS.

Biophys J. 2011 Feb 16;100(4):1139-48. doi: 10.1016/j.bpj.2010.08.080.

3.

Fluorescent labeling of tetracysteine-tagged proteins in intact cells.

Hoffmann C, Gaietta G, Zürn A, Adams SR, Terrillon S, Ellisman MH, Tsien RY, Lohse MJ.

Nat Protoc. 2010 Sep;5(10):1666-77. doi: 10.1038/nprot.2010.129. Epub 2010 Sep 23.

4.

Sensing G protein-coupled receptor activation.

Ambrosio M, Zürn A, Lohse MJ.

Neuropharmacology. 2011 Jan;60(1):45-51. doi: 10.1016/j.neuropharm.2010.08.006. Epub 2010 Aug 18. Review.

PMID:
20727363
5.

Formation of a ternary complex among NHERF1, beta-arrestin, and parathyroid hormone receptor.

Klenk C, Vetter T, Zürn A, Vilardaga JP, Friedman PA, Wang B, Lohse MJ.

J Biol Chem. 2010 Sep 24;285(39):30355-62. doi: 10.1074/jbc.M110.114900. Epub 2010 Jul 23.

6.

Site-specific, orthogonal labeling of proteins in intact cells with two small biarsenical fluorophores.

Zürn A, Klenk C, Zabel U, Reiner S, Lohse MJ, Hoffmann C.

Bioconjug Chem. 2010 May 19;21(5):853-9. doi: 10.1021/bc900394j.

PMID:
20429545
7.

Regulation of the glutamate transporter EAAT4 by PIKfyve.

Alesutan IS, Ureche ON, Laufer J, Klaus F, Zürn A, Lindner R, Strutz-Seebohm N, Tavaré JM, Boehmer C, Palmada M, Lang UE, Seebohm G, Lang F.

Cell Physiol Biochem. 2010;25(2-3):187-94. doi: 10.1159/000276569. Epub 2010 Jan 12.

8.

[Chromatographic determination of radiochemical purity - replacement of ITLC SG].

Wunderlich G, Herrling P, Zürn A, Anders P, Kotzerke J.

Nuklearmedizin. 2010;49(2):73-7. doi: 10.3413/nukmed-0279. Epub 2009 Dec 22. German.

PMID:
20029681
9.

Regulation of the glutamate transporter EAAT2 by PIKfyve.

Gehring EM, Zurn A, Klaus F, Laufer J, Sopjani M, Lindner R, Strutz-Seebohm N, Tavaré JM, Boehmer C, Palmada M, Lang UE, Seebohm G, Lang F.

Cell Physiol Biochem. 2009;24(5-6):361-8. doi: 10.1159/000257428. Epub 2009 Nov 4.

10.

Differential proteoglycan expression in two spinal cord regions after dorsal root injury.

Waselle L, Quaglia X, Zurn AD.

Mol Cell Neurosci. 2009 Dec;42(4):315-27. doi: 10.1016/j.mcn.2009.08.004. Epub 2009 Aug 14.

PMID:
19683574
11.

Regulation of the Na(+)-coupled glutamate transporter EAAT3 by PIKfyve.

Klaus F, Gehring EM, Zürn A, Laufer J, Lindner R, Strutz-Seebohm N, Tavaré JM, Rothstein JD, Boehmer C, Palmada M, Gruner I, Lang UE, Seebohm G, Lang F.

Neurochem Int. 2009 May-Jun;54(5-6):372-7.

PMID:
19418632
12.

Local delivery of glial cell line-derived neurotrophic factor improves facial nerve regeneration after late repair.

Barras FM, Kuntzer T, Zurn AD, Pasche P.

Laryngoscope. 2009 May;119(5):846-55. doi: 10.1002/lary.20169.

PMID:
19266571
13.
14.

Fluorescence resonance energy transfer analysis of alpha 2a-adrenergic receptor activation reveals distinct agonist-specific conformational changes.

Zürn A, Zabel U, Vilardaga JP, Schindelin H, Lohse MJ, Hoffmann C.

Mol Pharmacol. 2009 Mar;75(3):534-41. doi: 10.1124/mol.108.052399. Epub 2008 Dec 23.

PMID:
19106230
15.

Persisting atypical and cystic forms of Borrelia burgdorferi and local inflammation in Lyme neuroborreliosis.

Miklossy J, Kasas S, Zurn AD, McCall S, Yu S, McGeer PL.

J Neuroinflammation. 2008 Sep 25;5:40. doi: 10.1186/1742-2094-5-40.

16.

Delayed priming promotes CNS regeneration post-rhizotomy in Neurocan and Brevican-deficient mice.

Quaglia X, Beggah AT, Seidenbecher C, Zurn AD.

Brain. 2008 Jan;131(Pt 1):240-9. Epub 2007 Dec 7.

PMID:
18065437
17.

Conformational changes in G-protein-coupled receptors-the quest for functionally selective conformations is open.

Hoffmann C, Zürn A, Bünemann M, Lohse MJ.

Br J Pharmacol. 2008 Mar;153 Suppl 1:S358-66. Epub 2007 Dec 3. Review.

18.

Regeneration failure in the CNs: cellular and molecular mechanisms.

Zurn AD, Bandtlow CE.

Adv Exp Med Biol. 2006;557:54-76. Review. No abstract available.

PMID:
16955704
19.

Lentivirus-mediated expression of glutathione peroxidase: neuroprotection in murine models of Parkinson's disease.

Ridet JL, Bensadoun JC, Déglon N, Aebischer P, Zurn AD.

Neurobiol Dis. 2006 Jan;21(1):29-34. Epub 2005 Jul 14.

PMID:
16023352
20.

Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment.

Zala D, Benchoua A, Brouillet E, Perrin V, Gaillard MC, Zurn AD, Aebischer P, Déglon N.

Neurobiol Dis. 2005 Dec;20(3):785-98. Epub 2005 Jul 11.

PMID:
16006135
21.

Increased fiber outgrowth from xeno-transplanted human embryonic dopaminergic neurons with co-implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor.

Ahn YH, Bensadoun JC, Aebischer P, Zurn AD, Seiger A, Björklund A, Lindvall O, Wahlberg L, Brundin P, Kaminski Schierle GS.

Brain Res Bull. 2005 Jul 30;66(2):135-42.

PMID:
15982530
22.

Lesion-induced differential expression and cell association of Neurocan, Brevican, Versican V1 and V2 in the mouse dorsal root entry zone.

Beggah AT, Dours-Zimmermann MT, Barras FM, Brosius A, Zimmermann DR, Zurn AD.

Neuroscience. 2005;133(3):749-62.

PMID:
15896911
23.
24.

Glial cell line-derived neurotrophic factor released by synthetic guidance channels promotes facial nerve regeneration in the rat.

Barras FM, Pasche P, Bouche N, Aebischer P, Zurn AD.

J Neurosci Res. 2002 Dec 15;70(6):746-55.

PMID:
12444596
25.

GDNF and NGF released by synthetic guidance channels support sciatic nerve regeneration across a long gap.

Fine EG, Decosterd I, Papaloïzos M, Zurn AD, Aebischer P.

Eur J Neurosci. 2002 Feb;15(4):589-601.

PMID:
11886440
26.

Nerve growth factor- and neurotrophin-3-releasing guidance channels promote regeneration of the transected rat dorsal root.

Bloch J, Fine EG, Bouche N, Zurn AD, Aebischer P.

Exp Neurol. 2001 Dec;172(2):425-32.

PMID:
11716566
27.

Sustained delivery of GDNF: towards a treatment for Parkinson's disease.

Zurn AD, Widmer HR, Aebischer P.

Brain Res Brain Res Rev. 2001 Oct;36(2-3):222-9. Review.

PMID:
11690619
28.

Isolation of multipotent neural precursors residing in the cortex of the adult human brain.

Arsenijevic Y, Villemure JG, Brunet JF, Bloch JJ, Déglon N, Kostic C, Zurn A, Aebischer P.

Exp Neurol. 2001 Jul;170(1):48-62.

PMID:
11421583
29.

Evaluation of an intrathecal immune response in amyotrophic lateral sclerosis patients implanted with encapsulated genetically engineered xenogeneic cells.

Zurn AD, Henry H, Schluep M, Aubert V, Winkel L, Eilers B, Bachmann C, Aebischer P.

Cell Transplant. 2000 Jul-Aug;9(4):471-84.

PMID:
11038064
30.
31.

Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF.

Bensadoun JC, Déglon N, Tseng JL, Ridet JL, Zurn AD, Aebischer P.

Exp Neurol. 2000 Jul;164(1):15-24.

PMID:
10877911
32.

Increased motoneuron survival and improved neuromuscular function in transgenic ALS mice after intraspinal injection of an adeno-associated virus encoding Bcl-2.

Azzouz M, Hottinger A, Paterna JC, Zurn AD, Aebischer P, Büeler H.

Hum Mol Genet. 2000 Mar 22;9(5):803-11.

PMID:
10749988
33.

Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease.

Déglon N, Tseng JL, Bensadoun JC, Zurn AD, Arsenijevic Y, Pereira de Almeida L, Zufferey R, Trono D, Aebischer P.

Hum Gene Ther. 2000 Jan 1;11(1):179-90.

PMID:
10646649
34.

Attenuation of 6-OHDA-induced neurotoxicity in glutathione peroxidase transgenic mice.

Bensadoun JC, Mirochnitchenko O, Inouye M, Aebischer P, Zurn AD.

Eur J Neurosci. 1998 Oct;10(10):3231-6.

PMID:
9786216
35.

Intrathecal implants of bovine chromaffin cells alleviate mechanical allodynia in a rat model of neuropathic pain.

Décosterd I, Buchser E, Gilliard N, Saydoff J, Zurn AD, Aebischer P.

Pain. 1998 May;76(1-2):159-66.

PMID:
9696469
36.

Neurturin protects dopaminergic neurons following medial forebrain bundle axotomy.

Tseng JL, Bruhn SL, Zurn AD, Aebischer P.

Neuroreport. 1998 Jun 1;9(8):1817-22.

PMID:
9665607
37.

Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts.

Sautter J, Tseng JL, Braguglia D, Aebischer P, Spenger C, Seiler RW, Widmer HR, Zurn AD.

Exp Neurol. 1998 Jan;149(1):230-6.

PMID:
9454632
38.

A gene therapy approach for the treatment of amyotrophic lateral sclerosis and Parkinson's disease.

Zurn AD, Tseng JL, Déglon N, Joseph JM, Aebischer P.

Adv Pharmacol. 1998;42:929-31. No abstract available.

PMID:
9328050
39.
40.

Neuronal GDNF expression in the adult rat nervous system identified by in situ hybridization.

Pochon NA, Menoud A, Tseng JL, Zurn AD, Aebischer P.

Eur J Neurosci. 1997 Mar;9(3):463-71.

PMID:
9104588
41.
42.

Central nervous system delivery of recombinant ciliary neurotrophic factor by polymer encapsulated differentiated C2C12 myoblasts.

Déglon N, Heyd B, Tan SA, Joseph JM, Zurn AD, Aebischer P.

Hum Gene Ther. 1996 Nov 10;7(17):2135-46.

PMID:
8934227
43.

Rescue of motoneurons from axotomy-induced cell death by polymer encapsulated cells genetically engineered to release CNTF.

Tan SA, Déglon N, Zurn AD, Baetge EE, Bamber B, Kato AC, Aebischer P.

Cell Transplant. 1996 Sep-Oct;5(5):577-87.

PMID:
8889216
44.

Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients.

Aebischer P, Schluep M, Déglon N, Joseph JM, Hirt L, Heyd B, Goddard M, Hammang JP, Zurn AD, Kato AC, Regli F, Baetge EE.

Nat Med. 1996 Jun;2(6):696-9. Erratum in: Nat Med 1996 Sep;2(9):1041.

PMID:
8640564
45.

Gene therapy for amyotrophic lateral sclerosis (ALS) using a polymer encapsulated xenogenic cell line engineered to secrete hCNTF.

Aebischer P, Pochon NA, Heyd B, Deglon N, Joseph JM, Zurn AD, Baetge EE, Hammang JP, Goddard M, Lysaght M, Kaplan F, Kato AC, Schluep M, Hirt L, Regli F, Porchet F, De Tribolet N.

Hum Gene Ther. 1996 May 1;7(7):851-60.

PMID:
8860837
46.

Combined effects of GDNF, BDNF, and CNTF on motoneuron differentiation in vitro.

Zurn AD, Winkel L, Menoud A, Djabali K, Aebischer P.

J Neurosci Res. 1996 Apr 15;44(2):133-41.

PMID:
8723221
47.

Treatment of Parkinson's disease. Symptomatic cell therapies: cells as biological minipumps.

Zurn AD, Tseng J, Aebischer P.

Eur Neurol. 1996;36(6):405-8. Review. No abstract available.

PMID:
8954314
48.

Encapsulation of neurotrophic factor-releasing cells for the treatment of neurodegenerative diseases.

Aebischer P, Tan SA, Déglon N, Heyd B, Zurn A, Baetge E, Sagot Y, Kato A.

Restor Neurol Neurosci. 1995 Jan 1;8(1):65-6. doi: 10.3233/RNN-1995-81215. No abstract available.

PMID:
21551809
49.

IgM autoantibodies to 180- and 230- to 240-kd human epidermal proteins in pregnancy.

Borradori L, Didierjean L, Bernard P, Tamm K, Gaucherand M, Zurn A, Saurat JH.

Arch Dermatol. 1995 Jan;131(1):43-7.

PMID:
7826095
50.

Glial cell line-derived neurotrophic factor (GDNF), a new neurotrophic factor for motoneurones.

Zurn AD, Baetge EE, Hammang JP, Tan SA, Aebischer P.

Neuroreport. 1994 Dec 30;6(1):113-8.

PMID:
7703397

Supplemental Content

Support Center